Dr. Charles Joseph Hornberger Sr., OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 8425 Boston State Road, Boston, NY 14025 Phone: 716-941-5585 Fax: 716-941-9281 |
News Archive
Although common opinion holds that exposure to pesticides increases adverse birth outcomes, the existing body of scientific evidence is ambiguous. Logistical and ethical barriers - pesticide use data are not widely available and randomized control trials are impossible - have gotten in the way of more accurate conclusions.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified the process by which stem cells in the airways of the lungs switch between two distinct phases - creating more of themselves and producing mature airway cells - to regenerate lung tissue after an injury.
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
For decades, American waistlines have been expanding and there is increasing cause for alarm. Researchers from the Charles E. Schmidt College of Medicine at Florida Atlantic University make the case that metabolic syndrome - a cluster of three of more risk factors that include abdominal obesity, high triglycerides, high blood pressure, abnormal lipids, and insulin resistance, a precursor of type 2 diabetes - is the new "silent killer," analogous to hypertension in the 1970s.
› Verified 4 days ago